Sex hormone-related polymorphisms in endometriosis and migraine: A narrative review

Abstract

Some evidence indicates endometriosis and migraine have a common genetic predisposition in sex-hormone genes, which could have important implications for the treatment of these two heterogenous conditions. To date, the genes responsibility remains unknown. Based on the biological hypothesis that polymorphisms of genes involved in sex-hormone pathways may influence estrogen levels and phenotypes of both disorders, we did a literature search for candidate sex-hormone genes and genes involved in the metabolism of estradiol. The aim was to review the evidence for shared sex-hormone-related polymorphisms between endometriosis and migraine and provide an exhaustive overview of the current literature. We included case-control studies investigating associations between candidate sex-hormone-related genes and the disorders endometriosis and migraine, respectively. Results showed three overlapping sex-hormone-associated polymorphisms in estrogen receptor genes that are associated with both conditions. To confirm possible associations with other sex-hormone genes, larger studies are needed.

Keywords

endometriosis migraine polymorphism sex hormone genes sex hormone receptor

Introduction

Endometriosis and migraine are two distinctive disorders associated with chronic pain, inflammation and a high grade of disability. Endometriosis is a common gynecological disease where endometrium-like tissue is manifested outside the uterine cavity.¹ Migraine, on the other hand, is a neurological disorder distinguished by recurrent headache attacks.² Based on the high prevalence in women during their reproductive life phase, it is assumed that estrogens or other female sex hormones might play a crucial role in the pathophysiology of both conditions. There is also some evidence that both conditions might share a common genetic background.^3,4 The lifetime prevalence of endometriosis is at least 10% and the global prevalence of migraine in women is 18.9%, which corresponds to over a billion women suffering worldwide.^5,6 Both conditions generate a huge social and economic burden and exert a significant negative impact on women’s quality of life.^7–9 Migraine is the number one cause of disability in women during their reproductive years (aged 15 - 49 years).^10,11 Large twin studies indicate that both disorders have a heritable trait, with heritability estimated to be between 30–60% for migraine and circa 50% for endometriosis, indicating that genes are of importance in the etiology of both conditions.^12–16 Therefore, it has been suggested that endometriosis and migraine might be comorbidities, at least in a subset of women.³ Menstruation is a major trigger for endometriosis-associated pain and menstrual-related migraine.^17,18 In women, migraine typically starts during puberty and resolves during menopause. More than 50% of women report an association between migraine and their menstrual bleeding.¹⁹ Both disorders are estrogen-dependent and may lead to exceptionally strong symptoms during menstruation.^18,20

The role of female sex hormones in the pathogenesis of migraine is well established.²¹ The drop of estrogen levels at the end of the menstrual cycle and at the beginning of the hormone-free interval in users of exogenous estrogens plays a crucial role in the pathophysiology of migraines in women.^22–24 In addition, it has been shown that the use of combined oral contraceptives in the standard regimen may initiate and worsen migraine in predisposed women.^25–28 Interestingly, a positive impact on the frequency of migraine episodes and the intensity of pain was observed in a continuous regimen with Desogestrel, a progestin-only contraceptive.^29,30 Likewise, endometriosis symptoms can be successfully treated with hormones, in particular progestins.^31,32

In line with the biological hypothesis that polymorphisms of genes involved in sex-hormone pathways may influence estrogen levels, we aimed to study the main sex-hormone genes (ESR1, ESR2, PGR, FSHR, AR, SHBG) and selected the most regularly studied genes affecting the metabolism of estradiol (COMT, NRIP1, CYP1A1, CYP17A1, CYP19A1).³³ There are two types of estrogen receptor (ESR) genes; estrogen receptor 1 (ESR1 or ER-alpha) and estrogen receptor 2 (ESR2 or ER-beta). Estrogen levels rise in the early phase of the cycle as a result of increasing levels of follicle stimulating hormone (FSH). During the menstrual cycle, not only estrogen levels but also levels of FSH, progesterone, and androgens fluctuate. Therefore, FSH receptor (FSHR), progesterone receptor (PGR), and androgen receptor (AR) genes must also be investigated as a potential source for a genetic predisposition. The PGR gene has two protein isoforms that modulate the biological action of progesterone: isoform A (PRA), which is capable of inhibiting the activation of the estrogen receptors, and isoform B (PRB), which has the capacity to activate the estrogen receptors.³⁴ Similar to the ESR, the PGR can undergo ligand-independent activation and is involved in various intracellular signaling pathways. A specific polymorphism in the PGR gene called PROGINS seems to impact the ligand-binding and the entire signaling pathway.³⁵ Moreover, the sex hormone-binding globulin (SHBG) gene, which codes for a glycoprotein that binds to androgens and estrogens, is of interest. For the final step of estrogen biosynthesis, aromatase enzymes such as Cytochrome P450, family 19, subfamily A, polypeptide 1 (CYP19A1), which is involved in the conversion of androgen to estrogen, are essential. Another enzyme of this family, Cytochrome P450, Family 17, subfamily A, polypeptide 1 (CYP17A1), mediates both 17-alpha-hydroxylase and 17,20-lyase, which play a key role in androgen biosynthesis.³⁶ Finally, Cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1) participates in this process by catalyzing estrogen hydroxylation in extrahepatic tissues.³⁷ Other genes involved in estrogen metabolism, like catechol-estrogen or its products, including catechol-O-methyl-transferase (COMT) and nuclear receptor interacting protein 1 (NRIP1), could also have an impact. NRIP1 negatively regulates the transcription of estrogen receptors, particularly ESR1.³⁸ Catechol-O-methyltransferase (COMT) is an omnipresent enzyme of the estrogen metabolizing pathway that catalyzes O-methylation and subsequently inactivates estradiol metabolites.³⁹

The association between most of these sex hormone gene variants (ESR1, ESR2, PGR, FSHR, AR, SBHG) and estradiol-metabolizing enzymes (NRIP1, COMT, and CYP family members) has been studied in women with migraine or endometriosis, however mostly for each disorder separately.^40–42 One large Australian family study with 815 monozygotic and 457 dizygotic twin-pair sisters with surgically confirmed endometriosis investigated whether the combination of the two conditions is the result of chance, selection bias, or common environmental and genetic factors. The findings suggest that endometriosis and migraine have common genetic predispositions with a bivariate heritability of 17%.³

To our knowledge, no previous study has specifically assessed the shared polymorphism between endometriosis and migraine. A possible genetic link could lead to better therapeutic care of these patients who suffer from chronic pain.

The aim of this narrative review is to obtain evidence for shared sex-hormone related polymorphisms in migraine and endometriosis. We aspire to present a comprehensive review of the existing literature and rationale for new research. We included studies focusing on sex-hormone receptor polymorphisms as well as those investigating enzymes affecting the metabolism of estradiol.

Materials and methods

Search strategy

We searched the PubMed database for publications from between January 2000 and July 2021 on sex hormone polymorphisms in endometriosis and migraine, respectively. To search and include as many related studies as possible, we used the MeSH terms “endometriosis” and “migraine disorders” with different combinations of the keywords for each sex hormone receptor. For Estrogen Receptor 1, for example, we used: ESR1, ESR1 gene, ESR alpha, ESR alpha gene, ESR1 polymorphism, ESR alpha polymorphism, estrogen receptor alpha polymorphism, estrogen receptor 1 polymorphism. We did the same for ESR2, FSHR, PGR, AR, SHBG and the estrogen-metabolizing association genes NRIP1, CYP1A1, CYP17A1, CYP19A1 and COMT. For each sex hormone-related gene included in the present study, a literature search was performed to find case-control studies and potential previous reviews and/or meta-analyses in order to identify potential additional records through other sources.

Study selection

The eligibility of each publication was assessed independently by two reviewers (JFV and GM). After the titles and abstracts were screened, the full text of articles eligible for our review was examined. Studies had to meet the following inclusion criteria: 1) published between January 2000—July 2021, 2) original case-control study investigating associations between polymorphisms in the candidate sex hormone genes (ESR1, ESR2, FSHR, PGR, AR, SHBG) and the estradiol metabolizing association genes (NRIP1, CYP1A1, CYP17A1, CYP19A1, COMT) and 3) diagnosis of endometriosis confirmed by surgery and/or histology and diagnosis of migraine according to the criteria of the International Headache Society (IHS).² While reviewing publications, a novel gene, the FSH beta-subunit (FSHB) gene, consisting of a FSH beta-subunit (FSHβ), was added to our gene selection.⁴³ A new literature search for this FSHB gene was carried out. We excluded systematic reviews and/or meta-analyses, commentary articles, and duplicated studies. In the endometriosis studies, control groups with unrelated males or neonates were excluded, considering endometriosis is a disease occurring in women of reproductive age. However, we included one study with a very large sample size that included both parents of the women with endometriosis, due to their comparable hereditary genetic makeup. Studies with self-reported or self-diagnosed endometriosis or migraine were excluded. We excluded two case-control studies that investigated the combination of two sex hormone polymorphisms^44,45 (Supplemental Table S1). Figure 1 summarizes the study selection process for identifying eligible studies.

Figure 1.

Flow diagram of the literature search and study selection process.

Data extraction

For each eligible study, data were extracted by one investigator (JFV) using a standardized Microsoft Excel spreadsheet and checked by a second investigator (GM). Discrepancies were resolved through discussion. The following data were listed for each study: Author, year of publication, country in which the research was conducted, ethnicity of the women, sample size, sex hormone gene, dbSNP (RefSNP or rs),⁴⁶ associated alleles if available, and the type of genetic analysis. For the endometriosis studies, we also extracted the type of control population and the endometriosis stage according to the American Society for Reproductive Medicine (ASRM) classification or the American Fertility Society score (AFS) respectively, if available.⁴⁷

Results

In total, 92 studies fulfilled the inclusion criteria for this review (Figure 1). The characteristics of the included studies are listed in Table 1. For some of the candidate genes, a broad variety of SNPs were investigated. SNPs that were mentioned more than once in our literature search are grouped, see Table 1. Other SNPs that have been mentioned only once in our search are listed at the end. In the CYP17A1 gene, SHBG gene, and FSHB gene, the SNPs have only been assessed in one of both conditions. Since we are looking for overlapping SNPs between both conditions, these SNPs will not be described in our results but can be found in Table 1.

Table 1.

Summary table of the included studies according to sex-hormone genes.

Gene	Polymorphism	Allele	Association	Disease	Ref. citation	Cases/Controls	Ethnicity	Country	Analysis	Cases Surgery Yes/No	Control Surgery Yes/No	ASRM	IHS
ESR1	rs2234693, Pvull	T > C	Yes	Endometriosis	Hsieh et al.⁴⁸	112/110	Asian	Taiwan	PCR-RFLP	Yes	No	Yes
ESR1	rs2234693, Pvull	T > C	Yes	Endometriosis	Lamp et al.⁴⁹	150/199	Caucasian	Estonia	PCR-RFLP	Yes	No	Yes
ESR1	rs2234693, Pvull	C > T	Yes	Endometriosis	Paskulin et al.⁵⁰	98/115	Caucasian	Brazil	Taqman assay	Yes	Yes	Yes
ESR1	rs2234693, Pvull	^*	Yes	Endometriosis	Kitawaki et al.⁵¹	109/179	Asian	Japan	PCR-RFLP	Yes	No	Yes
ESR1	rs2234693, Pvull	T > C	No	Endometriosis	Govindan et al.⁵²	110/115	Asian	India	PCR-RFLP	Yes	No	Yes
ESR1	rs2234693, Pvull	T > C	No	Endometriosis	Renner et al.⁵³	98/98	Caucasian	Germany	PCR-RFLP	Yes	No	Yes
ESR1	rs2234693, Pvull	^*	No	Endometriosis	Xie et al.⁵⁴	214/160	Asian	China	PCR-RFLP	Yes	No	No
ESR1	rs2234693, Pvull	^*	Yes	Migraine	An et al.⁵⁵	494/533	Asian	China	MALDI-TOF MS				Yes
ESR1	rs2234693, Pvull	C > T	Yes	Migraine	Ghosh et al.⁵⁶	334/200	Asian	India	PCR-SSCP				Yes
ESR1	rs2234693, Pvull	T > C	Yes	Migraine	Joshi et al.⁵⁷	217/217	Asian	India	PCR-RFLP				Yes
ESR1	rs2234693, Pvull	C > T	No	Migraine	Colson et al.⁵⁸	240/240	Caucasian	Australia	PCR-RFLP				Yes
ESR1	rs9340799, Xbal	A > G	Yes	Endometriosis	Hsieh et al.⁴⁸	112/110	Asian	Taiwan	PCR-RFLP	Yes	No	Yes
ESR1	rs9340799, Xbal	A > G	Yes	Endometriosis	Xie et al.⁵⁴	214/160	Asian	China	PCR-RFLP	Yes	No	No
ESR1	rs9340799, Xbal	A > G	No	Endometriosis	Renner et al.⁵³	98/98	Caucasian	Germany	PCR-RFLP	Yes	No	Yes
ESR1	rs9340799, Xbal	A > G	No	Endometriosis	Paskulin et al.⁵⁰	98/115	Caucasian	Brazil	Taqman assay	Yes	Yes	Yes
ESR1	rs9340799, Xbal	^*	Yes	Migraine	An et al.⁵⁵	494/533	Asian	China	MALDI-TOF MS				Yes
ESR1	rs9340799, Xbal	^*	No	Migraine	Ghosh et al.⁵⁶	334/200	Asian	India	PCR-SSCP				Yes
ESR1	TA repeat	(TA)n	Yes	Endometriosis	Kim et al.⁵⁹	180/165	Asian	Korea	PCR-RFLP	Yes	Yes	Yes
ESR1	TA repeat	(TA)n	Yes	Endometriosis	Hsieh et al.⁶⁰	119/108	Asian	Taiwan	PCR-RFLP	Yes	Yes	Yes
ESR1	TA repeat	(TA)n	Yes	Endometriosis	Lamp et al.⁴⁹	150/199	Caucasian	Estonia	PCR-RFLP	Yes	No	Yes
ESR1	rs2228480	^*	No	Endometriosis	Wu et al.⁶¹	121/171	Asian	Taiwan	Taqman assay	Yes	No	Yes
ESR1	rs2228480	G > A	Yes	Migraine	Colson et al.⁶²	224/224	Caucasian	Australia	PCR				Yes
ESR1	rs2228480	G > A	Yes	Migraine	An et al.⁵⁵	494/533	Asian	China	MALDI-TOF MS				Yes
ESR1	rs2228480	G > A	No	Migraine	Coşkun et al.⁶³	142/141	Asian	Turkey	PCR				Yes
ESR1	rs2228480	G > A	No	Migraine	Kaunisto et al.⁶⁴	898/900	Caucasian	Finland	Multiplex-PCR				Yes
ESR1	rs2228480	G > A	No	Migraine	Oterino et al.⁶⁵	599/232	Caucasian	Spain	Real-Time PCR assay				Yes
ESR1	rs2228480	G > A	No	Migraine	Corominas et al.⁶⁶	210/210	Caucasian	Spain	PCR-RFLP				Yes
ESR1	rs2228480	G > A	No	Migraine	Ghosh et al.⁵⁶	334/200	Asian	India	PCR-SSCP				Yes
ESR1	rs2228480	G > A	No	Migraine	Rodriguez-Acevedo et al.⁶⁷	282/155	Caucasian	Australia	PCR-RFLP				Yes
ESR1	rs1801132	^*	No	Endometriosis	Wu et al.⁶¹	121/171	Asian	Taiwan	Taqman assay	Yes	No	Yes
ESR1	rs1801132	C > G	Yes	Migraine	Kaunisto et al.⁶⁴	898/900	Caucasian	Finland	Multiplex-PCR				Yes
ESR1	rs1801132	G > C	Yes	Migraine	Oterino et al.⁶⁵	599/232	Caucasian	Spain	Real-Time PCR assay				Yes
ESR1	rs1801132	G > C	Yes	Migraine	Oterino et al.⁶⁸	356/374	Caucasian	Spain	Real-Time PCR assay				Yes
ESR1	rs1801132	^*	No	Migraine	Coşkun et al.⁶³	142/141	Asian	Turkey	PCR				Yes
ESR1	rs1801132	C > G	No	Migraine	Colson et al.⁵⁸	240/240	Caucasian	Australia	PCR-RFLP				Yes
ESR1	rs1801132	^*	No	Migraine	Corominas et al.⁶⁶	210/210	Caucasian	Spain	PCR-RFLP				Yes
ESR1	rs1801132	^*	No	Migraine	Ghosh et al.⁵⁶	334/200	Asian	India	PCR-SSCP				Yes
ESR1	rs1801132	C > G	No	Migraine	Joshi et al.⁵⁷	217/217	Asian	India	PCR-RFLP				Yes
ESR1	rs1801132	^*	No	Migraine	Rodriguez-Acevedo et al.⁶⁷	282/155	Caucasian	Australia	PCR-RFLP				Yes
ESR1	rs1801132	^*	No	Migraine	An et al.⁵⁵	494/533	Asian	China	MALDI-TOF MS				Yes
ESR1	rs3798573	A > G	Yes	Endometriosis	Wang W et al.⁶⁹	312/357	Asian	China	PCR-RFLP	Yes	Yes	Yes
ESR1	rs2077647	^*	No	Endometriosis	Wu et al.⁶¹	121/171	Asian	Taiwan	Taqman assay	Yes	No	Yes
ESR1	rs3853250	^*	No	Endometriosis	Trabert et al.⁴⁰	256/567	Caucasian	USA	PCR-RFLP	Yes	No	Yes
ESR1	rs3853251	^*	No	Endometriosis	Trabert et al.⁴⁰	256/567	Caucasian	USA	PCR-RFLP	Yes	No	Yes
ESR1	rs1159327	A > G	No	Endometriosis	Wang W et al.⁶⁹	312/357	Asian	China	PCR-RFLP	Yes	Yes	Yes
ESR1	rs3020348	A > C	No	Endometriosis	Wang W et al.⁶⁹	312/357	Asian	China	PCR-RFLP	Yes	Yes	Yes
ESR1	rs1884049	^*	No	Endometriosis	Matsuzaka et al.⁷⁰	100/143	Asian	Japan	PCR	Yes	Yes	Yes
ESR1	rs1884053	^*	No	Endometriosis	Matsuzaka et al.⁷⁰	100/143	Asian	Japan	PCR	Yes	Yes	Yes
ESR1	rs1884054	^*	No	Endometriosis	Matsuzaka et al.⁷⁰	100/143	Asian	Japan	PCR	Yes	Yes	Yes
ESR1	Intron 1 HaeIII	GGCC > GGCT	No	Endometriosis	Sato et al.⁷¹	105/125	Caucasian	Brazil	PCR-RFLP	Yes	No	Yes
ESR1	Exon 1 MspI	CCGG > CTGG	No	Endometriosis	Sato et al.⁷¹	105/125	Caucasian	Brazil	PCR-RFLP	Yes	No	Yes
ESR1	IVS1 –401 > C	^*	No	Endometriosis	Huber et al.⁷²	32/790	Caucasian	Austria	Multiplex-PCR	Yes	No	Yes
ESR1	rs6557170	G > A	Yes	Migraine	Kaunisto et al.⁶⁴	898/900	Caucasian	Finland	Multiplex-PCR				Yes
ESR1	rs6557171	C > T	Yes	Migraine	Kaunisto et al.⁶⁴	898/900	Caucasian	Finland	Multiplex-PCR				Yes
ESR1	rs2347867	A > G	Yes	Migraine	Kaunisto et al.⁶⁴	898/900	Caucasian	Finland	Multiplex-PCR				Yes
ESR1	rs4870062	T > G	Yes	Migraine	Kaunisto et al.⁶⁴	898/900	Caucasian	Finland	Multiplex-PCR				Yes
ESR1	rs726281	^*	Yes	Migraine	Coşkun et al.⁶³	142/141	Asian	Turkey	PCR				Yes
ESR1	rs2295193	^*	No	Migraine	Coşkun et al.⁶³	142/141	Asian	Turkey	PCR				Yes
ESR1	rs3798577	^*	No	Migraine	Coşkun et al.⁶³	142/141	Asian	Turkey	PCR				Yes
ESR1	rs2077647	^*	No	Migraine	Corominas et al.⁶⁶	210/210	Caucasian	Spain	PCR-RFLP				Yes
ESR2	rs4986938, AluI	G > A	Yes	Endometriosis	Bianco et al.⁷³	108/210	Caucasian	Brazil	PCR-RFLP	Yes	Yes	Yes
ESR2	rs4986938, AluI	G > A	Yes	Endometriosis	Szaflik et al.⁷⁴	100/100	Caucasian	Poland	Sanger sequencing	Yes	No	Yes
ESR2	rs4986938, AluI	^*	No	Endometriosis	Wu et al.⁶¹	121/171	Asian	Taiwan	Taqman assay	Yes	No	Yes
ESR2	rs4986938, AluI	G > A	No	Endometriosis	Lee et al.⁷⁵	239/287	Asian	Korea	PCR-RFLP	Yes	Yes	Yes
ESR2	rs4986938, AluI	^*	Yes	Migraine	Rodriguez-Acevedo et al.⁶⁷	282/155	Caucasian	Australia	Taqman assay				Yes
ESR2	rs4986938, AluI	^*	Yes	Migraine	Oterino et al.⁶⁸	356/374	Caucasian	Spain	Real-Time PCR assay				Yes
ESR2	rs4986938, AluI	^*	No	Migraine	Coşkun et al.⁶³	142/141	Asian	Turkey	PCR				Yes
ESR2	rs4986938, AluI	^*	No	Migraine	An et al.⁵⁵	494/533	Asian	China	MALDI-TOF MS				Yes
ESR2	rs1256049	^*	Yes	Endometriosis	Silva et al.⁷⁶	54/46	Caucasian	Brazil	PCR	Yes	No	Yes
ESR2	rs1256049	^*	No	Endometriosis	Wu et al.⁶¹	121/171	Asian	Taiwan	Taqman assay	Yes	No	Yes
ESR2	rs1256049	^*	No	Migraine	An et al.⁵⁵	494/533	Asian	China	MALDI-TOF MS			Yes
ESR2	rs1256049	^*	No	Migraine	Ghosh et al.⁵⁶	334/200	Asian	India	PCR-SSCP				Yes
ESR2	rs17179740	^*	Yes	Endometriosis	Smolarz et al.⁷⁷	200/200	Caucasian	Poland	HRM	Yes	No	Yes
ESR2	rs17179740	A > G	No	Endometriosis	Wang W et al.⁶⁹	312/357	Asian	China	PCR-RFLP	Yes	Yes	Yes
ESR2	rs928554, A > G	A > G	Yes	Endometriosis	Szaflik et al.⁷⁴	100/100	Caucasian	Poland	Sanger sequencing	Yes	No	Yes
ESR2	rs944052	^*	Yes	Endometriosis	Trabert et al.⁴⁰	256/567	Caucasian	USA	PCR-RFLP	Yes	No	Yes
ESR2	CA repeat	(CA)n	Yes	Endometriosis	Lamp et al.⁴⁹	150/199	Caucasian	Estonia	PCR-RFLP	Yes	No	Yes
ESR2	rs1255998	^*	No	Migraine	Coşkun et al.⁶³	142/141	Asian	Turkey	PCR				Yes
ESR2	rs1271572	^*	No	Migraine	Ghosh et al.⁵⁶	334/200	Asian	India	PCR-SSCP				Yes
PGR	PROGINS Alu ins	^*	Yes	Endometriosis	Costa et al.⁷⁸	54/45	Caucasian	Brazil	PCR-RFLP	Yes	No	No
PGR	PROGINS Alu ins	^*	Yes	Endometriosis	De Carvalho et al.⁷⁹	121/281	Caucasian	Brazil	PCR-RFLP	Yes	No	Yes
PGR	PROGINS Alu ins	^*	Yes	Endometriosis	Lattuada et al.⁸⁰	131/127	Caucasian	Italy	PCR-RFLP	Yes	Yes	Yes
PGR	PROGINS Alu ins	^*	Yes	Endometriosis	Wieser et al.^39,81	95/107	Caucasian	Austria	PCR-RFLP	Yes	Yes	Yes
PGR	PROGINS Alu ins	^*	No	Endometriosis	Lamp et al.⁴⁹	150/199	Caucasian	Estonia	PCR-RFLP	Yes	No	Yes
PGR	PROGINS Alu ins	^*	No	Endometriosis	Treloar et al.^82,83	980/2940	Caucasian	Australia	PCR-RFLP	Yes	No	Yes
PGR	PROGINS Alu ins	^*	No	Endometriosis	Gimenes et al.⁸⁴	148/179	Caucasian	Brazil	PCR-RFLP	Yes	Yes	Yes
PGR	PROGINS Alu ins	^*	No	Endometriosis	Govindan et al.⁸⁵	100/108	Asian	India	PCR	Yes	No	No
PGR	PROGINS Alu ins	^*	Yes	Migraine	Colson et al.⁸⁶	300/300	Caucasian	Australia	PCR				Yes
PGR	PROGINS Alu ins	^*	No	Migraine	Corominas et al.⁶⁶	210/210	Caucasian	Spain	PCR				Yes
PGR	PROGINS Alu ins	^*	No	Migraine	Rodriguez-Acevedo et al.⁶⁷	282/155	Caucasian	Australia	PCR				Yes
PGR	rs1042838	^*	No	Endometriosis	Trabert et al.⁴⁰	256/567	Caucasian	USA	PCR-RFLP	Yes	No	Yes
PGR	rs1042838	^*	No	Endometriosis	Wu et al.⁶¹	121/171	Asian	Taiwan	Taqman assay	Yes	No	Yes
PGR	rs1042838	G > T	No	Endometriosis	Treloar et al.^82,83	980/2940	Caucasian	Australia	PCR-RFLP	Yes	No	Yes
PGR	rs1042838	^*	No	Endometriosis	Van Kaam et al.⁸⁷	72/102	Caucasian	Netherlands	PCR-RFLP	Yes	Yes	Yes
PGR	rs1042838	^*	No	Migraine	Joshi et al.⁵⁷	217/217	Asian	India	PCR				Yes
PGR	rs1042838	G > T	No	Migraine	Palmirotta et al.⁸⁸	380/185	Caucasian	Italy	Sanger sequencing				Yes
PGR	rs10895068	G > A	No	Endometriosis	Van Kaam et al.⁸⁷	72/102	Caucasian	Netherlands	PCR-RFLP	Yes	Yes	Yes
PGR	rs10895068	G > A	No	Endometriosis	Gentilini et al.⁸⁹	199/300	Caucasian	Italy	PCR-RFLP	Yes	Yes	Yes
PGR	rs10895068	G > A	No	Endometriosis	Treloar et al.^82,83	980/2940	Caucasian	Australia	PCR-RFLP	Yes	No	Yes
PGR	rs10895068	G > A	No	Endometriosis	Lamp et al.⁴⁹	150/199	Caucasian	Estonia	PCR-RFLP	Yes	No	Yes
PGR	rs500760	A > G	Yes	Endometriosis	Treloar et al.^82,83	980/2940	Caucasian	Australia	PCR-RFLP	Yes	No	Yes
PGR	rs1042839	C > T	No	Endometriosis	Treloar et al.^82,83	980/2940	Caucasian	Australia	PCR-RFLP	Yes	No	Yes
PGR	rs2008112	G > A	No	Endometriosis	Treloar et al.^82,83	980/2940	Caucasian	Australia	PCR-RFLP	Yes	No	Yes
PGR	rs2020880	C > T	No	Endometriosis	Treloar et al.^82,83	980/2940	Caucasian	Australia	PCR-RFLP	Yes	No	Yes
PGR	rs3740754	G > C	No	Endometriosis	Treloar et al.^82,83	980/2940	Caucasian	Australia	PCR-RFLP	Yes	No	Yes
PGR	rs518162	G > A	No	Endometriosis	Treloar et al.^82,83	980/2940	Caucasian	Australia	PCR-RFLP	Yes	No	Yes
AR	CAG repeat	(CAG)n	Yes	Endometriosis	Hsieh et al.⁹⁰	110/99	Asian	Taiwan	PCR	Yes	No	No
AR	CAG repeat	(CAG)n	Yes	Endometriosis	Shaik et al.⁹¹	90/101	Asian	India	PCR	Yes	No	No
AR	CAG repeat	(CAG)n	Yes	Endometriosis	Shin et al.⁹²	421/349	Asian	Korea	PCR	Yes	Yes	Yes
AR	CAG repeat	(CAG)n	No	Endometriosis	Lattuada et al.⁹³	105/92	Caucasian	Italy	PCR	Yes	Yes	Yes
AR	CAG repeat	(CAG)n	No	Endometriosis	Tong et al.⁹⁴	24/114	Asian	China	PCR	Yes	No	Yes
AR	CAG repeat	(CAG)n	No	Migraine	Colson et al.⁸⁶	275/275	Caucasian	Australia	PCR				Yes
FSHR	rs6165	^*	Yes	Endometriosis	Kerimoglu et al.⁹⁵	100/100	Asian	Turkey	PCR-RFLP	Yes	Yes	Yes
FSHR	rs6165	^*	Yes	Endometriosis	Liaqat et al.⁹⁶	156/208	Asian	Pakistan	PCR	Yes	No	No
FSHR	rs6165	G > A	No	Endometriosis	Andre et al.⁹⁷	352/510	Caucasian	Brazil	Taqman assay	Yes	Yes	Yes
FSHR	rs6165	A > G	No	Endometriosis	Wang HS et al.⁹⁸	300/337	Asian	Taiwan	MALDI-TOF MS	Yes	No	Yes
FSHR	rs6166	^*	Yes	Endometriosis	Kerimoglu et al.⁹⁵	100/100	Asian	Turkey	PCR-RFLP	Yes	Yes	Yes
FSHR	rs6166	^*	No	Endometriosis	Liaqat et al.⁹⁶	156/208	Asian	Pakistan	PCR	Yes	No	No
FSHR	rs6166	A > G	No	Endometriosis	Andre et al.⁹⁷	352/510	Caucasian	Brazil	Taqman assay	Yes	Yes	Yes
FSHR	rs6166	A > G	No	Endometriosis	Wang HS et al.⁹⁸	300/337	Asian	Taiwan	MALDI-TOF MS	Yes	No	Yes
FSHR	rs6166	A > G	No	Endometriosis	Schmitz et al.⁹⁹	67/65	Caucasian	Brazil	PCR-RFLP	Yes	Yes	Yes
FSHR	rs6166	^*	Yes	Migraine	Oterino et al.⁶⁸	356/374	Caucasian	Spain	Real-Time PCR assay				Yes
FSHR	rs6166	^*	No	Migraine	Rodriguez-Acevedo et al.⁶⁷	282/155	Caucasian	Australia	MALDI-TOF MS				Yes
FSHR	rs6166	^*	No	Migraine	Coşkun et al.⁶³	142/141	Asian	Turkey	PCR				Yes
FSHB	rs11031006	^*	Yes	Endometriosis	Angioni et al.¹⁰⁰	72/41	Caucasian	Italy	Sanger sequencing	Yes	Yes	Yes
FSHB	rs11031006	^*	Yes	Endometriosis	Matalliotakis et al.¹⁰¹	166/150	Caucasian	Greece	Taqman assay	Yes	No	Yes
SHBG	rs6259	^*	No	Migraine	Coşkun et al.⁶³	142/141	Asian	Turkey	PCR				Yes
NRIP1	rs2229741	G > A	No	Endometriosis	Caballero et al.¹⁰²	59/141	Caucasian	Spain	Real-Time PCR assay	Yes	No	Yes
NRIP1	rs2229741	^*	Yes	Migraine	Rodriguez-Acevedo et al.⁶⁷	282/155	Caucasian	Australia	MALDI-TOF MS				Yes
NRIP1	rs2229741	^*	No	Migraine	Coşkun et al.⁶³	142/141	Asian	Turkey	PCR				Yes
NRIP1	rs2229741	^*	No	Migraine	Oterino et al.⁶⁸	356/374	Caucasian	Spain	Real-Time PCR assay				Yes
NRIP1	rs2229742	C > G	Yes	Endometriosis	Caballero et al.¹⁰²	59/141	Caucasian	Spain	Real-Time PCR assay	Yes	No	Yes
NRIP1	rs2506142	^*	Yes	Migraine	Pollock et al.¹⁰³	235/140	Caucasian	Australia	PCR-RFLP				Yes
COMT	rs4680	^*	No	Endometriosis	Christofolini et al.^44,104	198/168	Caucasian	Brazil	Taqman assay	Yes	Yes	Yes
COMT	rs4680	^*	No	Endometriosis	Trabert et al.⁴⁰	255/567	Caucasian	USA	PCR-RFLP	Yes	No	Yes
COMT	rs4680	G > A	No	Endometriosis	Wang HS et al.⁹⁸	300/337	Asian	Taiwan	MALDI-TOF MS	Yes	No	Yes
COMT	rs4680	G > A	No	Endometriosis	Wieser et al.^39,81	91/92	Caucasian	Australia	PCR-RFLP	Yes	Yes	Yes
COMT	rs4680	G > A	No	Endometriosis	Juo et al.¹⁰⁵	105/312	Asian	China	PCR-RFLP	Yes	No	No
COMT	rs4680	G > A	No	Endometriosis	Huber et al.⁷²	32/790	Caucasian	Austria	Multiplex-PCR	Yes	No	Yes
COMT	rs4680	G > A	Yes	Migraine	Emin Erdal et al.¹⁰⁶	62/64	Asian	Turkey	PCR-RFLP				Yes
COMT	rs4680	^*	Yes	Migraine	Sullivan et al.¹⁰⁷	1740/1132	Caucasian	USA	Illumina sequencing				Yes
COMT	rs4680	^*	No	Migraine	De Marchis et al.¹⁰⁸	380/132	Caucasian	Italy	Sanger sequencing				Yes
COMT	rs4680	^*	No	Migraine	Todt et al.¹⁰⁹	270/272	Caucasian	Germany	Taqman assay				Yes
COMT	rs4680	G > A	No	Migraine	Sutherland et al.¹¹⁰	268/140	Caucasian	Australia	PCR-RFLP				Yes
COMT	rs4680	G > A	No	Migraine	Takigawa et al.¹¹¹	223/191	Asian	Japan	PCR-RFLP				Yes
COMT	rs4680	G > A	No	Migraine	Hagen et al.¹¹²	982/1468	Caucasian	Norway	PCR				Yes
COMT	rs4680	G > A	No	Migraine	Park et al.¹¹³	97/94	Asian	Korea	PCR				Yes
COMT	rs1544325	^*	No	Migraine	Corominas et al.⁶⁶	259/287	Caucasian	Spain	SNPlex assay				Yes
COMT	rs165774	^*	No	Migraine	Corominas et al.⁶⁶	259/287	Caucasian	Spain	SNPlex assay				Yes
COMT	rs4633	C > T	No	Migraine	Takigawa et al.¹¹¹	223/191	Asian	Japan	PCR-RFLP				Yes
COMT	rs4646316	^*	No	Migraine	Corominas et al.⁶⁶	259/287	Caucasian	Spain	SNPlex assay				Yes
COMT	rs4818	^*	No	Migraine	De Marchis et al.¹⁰⁸	380/132	Caucasian	Italy	Sanger sequencing				Yes
COMT	rs6267	G > T	No	Migraine	Takigawa et al.¹¹¹	223/191	Asian	Japan	PCR-RFLP				Yes
COMT	rs740601	^*	No	Migraine	Corominas et al.⁶⁶	259/287	Caucasian	Spain	SNPlex assay				Yes
COMT	rs740603	^*	No	Migraine	Corominas et al.⁶⁶	259/287	Caucasian	Spain	SNPlex assay				Yes
COMT	rs9332377	^*	No	Migraine	Corominas et al.⁶⁶	259/287	Caucasian	Spain	SNPlex assay				Yes
COMT	rs933271	^*	No	Migraine	Corominas et al.⁶⁶	259/287	Caucasian	Spain	SNPlex assay				Yes
COMT	rs2020917	^*	No	Migraine	Corominas et al.⁶⁶	259/287	Caucasian	Spain	SNPlex assay				Yes
CYP1A1	rs4646903	^*	Yes	Endometriosis	Arvanitis et al.¹¹⁴	275/346	Caucasian	Greece	PCR	Yes	No	Yes
CYP1A1	rs4646903	T > C	Yes	Endometriosis	Barbosa et al.¹¹⁵	52/42	Caucasian	Brazil	PCR-RFLP	Yes	Yes	Yes
CYP1A1	rs4646903	T > C	No	Endometriosis	Babu et al.¹¹⁶	310/215	Asian	India	PCR-RFLP	Yes	Yes	Yes
CYP1A1	rs4646903	T > C	No	Endometriosis	Rozati et al.¹¹⁷	97/102	Asian	India	PCR-RFLP	Yes	Yes	Yes
CYP1A1	rs4646903	T > C	No	Endometriosis	Juo et al.¹⁰⁵	105/312	Asian	China	PCR-RFLP	Yes	No	No
CYP1A1	rs4646903	T > C	No	Endometriosis	Babaki et al.¹¹⁸	93/139	Asian	Iran	PCR-RFLP	Yes	Yes	Yes
CYP1A1	rs4646903	T > C	No	Endometriosis	Huber et al.⁷²	32/790	Caucasian	Austria	Multiplex-PCR	Yes	No	Yes
CYP1A1	rs4646903	^*	No	Endometriosis	Wu et al.¹¹⁹	121/171	Asian	Taiwan	Taqman assay	Yes	No	Yes
CYP1A1	rs4646903	T > C	No	Migraine	Sutherland et al.¹¹⁰	268/140	Caucasian	Australia	PCR-RFLP				Yes
CYP1A1	rs1048943	A > G	No	Endometriosis	Huber et al.⁷²	32/790	Caucasian	Austria	Multiplex-PCR	Yes	No	Yes
CYP1A1	rs1048943	A > G	No	Migraine	Sutherland et al.¹¹⁰	268/140	Caucasian	Australia	PCR-RFLP				Yes
CYP1A1	rs4646422	G > A	No	Endometriosis	Wang HS et al.⁹⁸	300/337	Asian	Taiwan	MALDI-TOF MS	Yes	No	Yes
CYP17A1	rs743572	T > C	Yes	Endometriosis	Bozdag et al.¹²⁰	46/39	Asian	Turkey	PCR	Yes	Yes	Yes
CYP17A1	rs743572	^*	Yes	Endometriosis	Hsieh et al.⁶⁰	119/108	Asian	Taiwan	PCR	Yes	Yes	No
CYP17A1	rs743572	A > G	Yes	Endometriosis	Szczepańska et al.¹²¹	115/197	Caucasian	Poland	HRM	Yes	Yes	Yes
CYP17A1	rs743572	T > C	No	Endometriosis	Vietri et al.¹²²	104/86	Caucasian	Italy	PCR	Yes	Yes	Yes
CYP17A1	rs743572	T > C	No	Endometriosis	De Carvalho et al.⁷⁹	121/281	Caucasian	Brazil	PCR-RFLP	Yes	No	No
CYP17A1	rs743572	T > C	No	Endometriosis	Huber et al.⁷²	32/790	Caucasian	Austria	Multiplex-PCR	Yes	No	Yes
CYP17A1	rs743572	T > C	No	Endometriosis	Vietri et al.¹²²	104/86	Caucasian	Italy	PCR	Yes	Yes	Yes
CYP17A1	rs743572	T > C	No	Endometriosis	Juo et al.¹⁰⁵	105/312	Asian	China	PCR-RFLP	Yes	No	No
CYP17A1	rs743572	^*	No	Endometriosis	Kado et al.³⁶	140/177	Asian	Japan	PCR-RFLP	Yes	No	Yes
CYP17A1	rs743572	^*	No	Endometriosis	Trabert et al.⁴⁰	256/567	Caucasian	USA	PCR-RFLP	Yes	No	Yes
CYP17A1	rs743572	^*	No	Endometriosis	Wu et al.⁶¹	121/171	Asian	Taiwan	Taqman assay	Yes	Yes	Yes
CYP17A1	rs619824	G > T	No	Endometriosis	Zhao et al.¹²³	768/768	Caucasian	Australia	MALDI-TOF MS	Yes	Yes	Yes
CYP17A1	rs3740397	C > G	No	Endometriosis	Zhao et al.¹²³	768/768	Caucasian	Australia	MALDI-TOF MS	Yes	Yes	Yes
CYP17A1	rs4919687	G > A	No	Endometriosis	Zhao et al.¹²³	768/768	Caucasian	Australia	MALDI-TOF MS	Yes	Yes	Yes
CYP17A1	rs6163	C > A	No	Endometriosis	Zhao et al.¹²³	768/768	Caucasian	Australia	MALDI-TOF MS	Yes	Yes	Yes
CYP17A1	rs6162	G > A	No	Endometriosis	Zhao et al.¹²³	768/768	Caucasian	Australia	MALDI-TOF MS	Yes	Yes	Yes
CYP17A1	rs743572	T > C	No	Endometriosis	Zhao et al.¹²³	768/768	Caucasian	Australia	MALDI-TOF MS	Yes	Yes	Yes
CYP17A1	rs2486758	T > C	No	Endometriosis	Zhao et al.¹²³	768/768	Caucasian	Australia	MALDI-TOF MS	Yes	Yes	Yes
CYP17A1	rs10786712	^*	No	Endometriosis	Wu et al.⁶¹	121/171	Asian	Taiwan	Taqman assay	Yes	No	Yes
CYP19A1	rs10046	^*	No	Endometriosis	Wu et al.⁶¹	121/171	Asian	Taiwan	Taqman assay	Yes	No	Yes
CYP19A1	rs10046	C > T	No	Endometriosis	Lamp et al.⁴⁹	150/199	Caucasian	Estonia	PCR-RFLP	Yes	No	Yes
CYP19A1	rs10046	C > T	No	Endometriosis	Szaflik et al.⁷⁴	100/100	Caucasian	Poland	Sanger sequencing	Yes	No	Yes
CYP19A1	rs10046	^*	No	Endometriosis	Szczepańska et al.¹²²	115/197	Caucasian	Poland	HRM	Yes	Yes	Yes
CYP19A1	rs10046	T > C	No	Endometriosis	Wang L et al.¹²⁴	146/225	Asian	China	PCR	Yes	No	No
CYP19A1	rs10046	^*	Yes	Migraine	Coşkun et al.⁶³	142/141	Asian	Turkey	PCR				Yes
CYP19A1	rs10046	^*	Yes	Migraine	Ghosh et al.⁵⁶	334/200	Asian	India	PCR-SSCP				Yes
CYP19A1	rs10046	^*	No	Migraine	Rodriguez-Acevedo et al.⁶⁷	282/155	Caucasian	Australia	MALDI-TOF MS				Yes
CYP19A1	rs10046	^*	No	Migraine	An et al.⁵⁵	494/533	Asian	China	MALDI-TOF MS				Yes
CYP19A1	rs10046	^*	No	Migraine	Oterino et al.⁶⁸	356/374	Caucasian	Spain	Real-Time PCR assay				Yes
CYP19A1	rs4646	C > A	No	Endometriosis	Szaflik et al.⁷⁴	100/100	Caucasian	Poland	Sanger sequencing	Yes	No	Yes
CYP19A1	rs4646	^*	Yes	Migraine	Ghosh et al.⁵⁶	334/200	Asian	India	PCR-SSCP				Yes
CYP19A1	rs4646	^*	No	Migraine	An et al.⁵⁵	494/533	Asian	China	MALDI-TOF MS				Yes
CYP19A1	rs4646	^*	No	Migraine	Rodriguez-Acevedo et al.⁶⁷	282/155	Caucasian	Australia	MALDI-TOF MS				Yes
CYP19A1	rs700519	C > T	No	Endometriosis	Wang HS et al.⁹⁸	300/337	Asian	Taiwan	MALDI-TOF MS	Yes	No	Yes
CYP19A1	rs700519	C > T	No	Endometriosis	Tsuchiya et al.³⁷	75/57	Asian	Japan	PCR	Yes	Yes	Yes
CYP19A1	rs700519	C > T	No	Endometriosis	Huber et al.⁷²	32/790	Caucasian	Austria	Multiplex-PCR	Yes	No	Yes
CYP19A1	rs700519	C > T	No	Migraine	Sutherland et al.¹¹⁰	268/140	Caucasian	Australia	PCR-RFLP				Yes
CYP19A1	rs2236722	T > C	No	Endometriosis	Wang HS et al.⁹⁸	300/337	Asian	Taiwan	MALDI-TOF MS	Yes	No	Yes
CYP19A1	rs2236722	T > C	No	Endometriosis	Wang L et al.¹²⁴	146/225	Asian	China	PCR	Yes	No	No
CYP19A1	TTTA repeat	(TTTA)n	Yes	Endometriosis	Arvanitis et al.¹¹⁴	275/346	Caucasian	Greece	PCR	Yes	No	Yes
CYP19A1	TTTA repeat	(TTTA)n	Yes	Endometriosis	Kado et al.³⁶	140/177	Asian	Japan	PCR-RFLP	Yes	No	Yes
CYP19A1	TTTA repeat	(TTTA)n	No	Endometriosis	Lamp et al.⁴⁹	150/199	Caucasian	Estonia	PCR-RFLP	Yes	No	Yes
CYP19A1	TTTA repeat	(TTTA)n	No	Endometriosis	Hur et al.¹²⁵	224/188	Asian	Korea	PCR	Yes	Yes	Yes
CYP19A1	TTTA repeat	(TTTA)n	No	Endometriosis	Wang L et al.¹²⁴	146/225	Asian	China	PCR	Yes	No	No
CYP19A1	Val80	G > A	Yes	Endometriosis	Vietri et al.¹²²	104/86	Caucasian	Italy	PCR	Yes	Yes	Yes
CYP19A1	Val80	G > A	No	Endometriosis	Hur et al.¹²⁵	224/188	Asian	Korea	PCR	Yes	Yes	Yes
CYP19A1	C1558T	C > T	Yes	Endometriosis	Vietri et al.¹²²	104/86	Caucasian	Italy	PCR	Yes	Yes	Yes
CYP19A1	C1558T	C > T	No	Endometriosis	Huber et al.⁷²	32/790	Caucasian	Austria	Multiplex-PCR	Yes	No	Yes
CYP19A1	rs1004982	^*	Yes	Endometriosis	Trabert et al.⁴⁰	256/567	Caucasian	USA	PCR-RFLP	Yes	No	Yes
CYP19A1	rs1870049	^*	Yes	Endometriosis	Trabert et al.⁴⁰	256/567	Caucasian	USA	PCR-RFLP	Yes	No	Yes
CYP19A1	rs936307	^*	Yes	Endometriosis	Trabert et al.⁴⁰	256/567	Caucasian	USA	PCR-RFLP	Yes	No	Yes
CYP19A1	rs8042086	^*	Yes	Endometriosis	Wu et al.⁶¹	121/171	Asian	Taiwan	Taqman assay	Yes	No	Yes
CYP19A1	TCT ins/del	^*	No	Endometriosis	Lamp et al.⁴⁹	150/199	Caucasian	Estonia	PCR-RFLP	Yes	No	Yes
CYP19A1	115T > C	^*	No	Endometriosis	Hur et al.¹²⁵	224/188	Asian	Korea	PCR	Yes	Yes	Yes
CYP19A1	1531C > T	^*	No	Endometriosis	Hur et al.¹²⁵	224/188	Asian	Korea	PCR	Yes	Yes	Yes
CYP19A1	rs700518	A > G	No	Endometriosis	Wang L et al.¹²⁴	146/225	Asian	China	PCR	Yes	No	No
CYP19A1	rs2899470	^*	Yes	Endometriosis	Smolarz et al.⁷⁷	200/200	Caucasian	Poland	HRM	Yes	No	Yes

ASRM: American Society for Reproductive Medicine; IHS: International Headache Society; ESR: estrogen receptor; PCR: polymerase chain reaction; PCR-SSCP: polymerase chain reaction-single-strand conformation polymorphism; PCR-RFLP: polymerase chain reaction-restriction fragment length polymorphism; HRM: high resolution melt; MALDI TOF MS: matrix-assisted laser desorption ionization-time-of-flight mass spectrometry; SNP: single nucleotide polymorphism; PGR: progesterone receptor; AR: androgen receptor; FSH: follicle stimulating hormone; FSHR: follicle stimulating hormone receptor; FSHB: FSH beta-subunit; SHBG: sex hormone-binding globulin; NRIP: nuclear receptor interacting protein; COMT: Catechol-O-methyl-transferase.

Not mentioned.

ESR1 gene

We found two overlapping polymorphisms in the ESR1 gene that could possibly play a role in the common genetic cause (Table 2).

Table 2.

Overview of overlapping polymorphisms associated with endometriosis and migraine.

		Association Endometriosis		Association Migraine
Gene	SNP	Caucasian	Asian	Caucasian	Asian
ESR1	rs2234693, Pvull	probable	probable	no	yes
ESR1	rs9340799, Xbal	no	yes	more studies needed	possible
ESR1	TA repeat	possible	yes	no data	no data
ESR1	rs2228480	no data	more studies needed	no	no
ESR1	rs1801132	no data	more studies needed	probable	no
ESR2	rs4986938, AluI	yes	no	yes	no
ESR2	rs1256049	no data	more studies needed	no data	no
ESR2	rs17179740	more studies needed	more studies needed	no data	no data
PGR	PROGINS Alu ins	possible	more studies needed	no	more studies needed
PGR	rs1042838	no	more studies needed	more studies needed	no data
PGR	rs10895068	no	no data	no data	no data
AR	CAG repeat	more studies needed	yes	more studies needed	more studies needed
FSHR	rs6165	more studies needed	probable	no data	no data
FSHR	rs6166	more studies needed	no	possible	no data
FSHB	rs11031006	yes	no data	no data	no data
SBHG	rs6259	no data	no data	no data	more studies needed
NRIP1	rs2229741	no data	no data	possible	more studies needed
COMT	rs4680	no	no	possible	no
CYP1A1	rs4646903, MspI	more studies needed	no	more studies needed	no data
CYP17A1	rs743572, MspA1	no	no	no data	no data
CYP19A1	rs10046	no	more studies needed	no	possible
CYP19A1	rs4646	more studies needed	no data	more studies needed	possible
CYP19A1	rs700519	no data	more studies needed	more studies needed	no data
CYP19A1	TTTA repeat	probable	possible	no data	no data

SNP: single nucleotide polymorphism; ESR: estrogen receptor; PGR: progesterone receptor; AR: androgen receptor; FSHR: follicle stimulating hormone receptor; FSHB: FSH beta-subunit; NRIP: nuclear receptor interacting protein; COMT: Catechol-O-methyl-transferase.

Yes: all studies showed an association.

Probable: ⩾ 50% with association AND largest sum of sample sizes.

Possible: ⩽ 50% with association BUT largest sum of sample sizes.

No: ⩾ 75% without association AND/OR large sample size without association.

More studies needed: ⩾ 2 studies needed for each disorder to make a statement.

No data.

rs2234693, Pvull

Four studies in endometriosis patients found an association of this polymorphism in Caucasian and Asian women,^51,48–50 while three studies did not.^52–54 This, in spite the sample sizes of the seven studies were comparable. Only two of four studies investigating the base-pair change T > C in different ethnicities found an association.^48,49,52,53 Three out of four studies found an association with migraine, all conducted in Asian populations, while no association with migraine was found in the study with a Caucasian population.^55–58 Only one study specified the affected base-pair change T > C.⁵⁷ Two large studies with Caucasian migraineurs did not find a significant association.^58,67

rs9340799, Xbal

Two of four studies found an association with endometriosis, and one of two studies found a significant association with migraine (Table 1). The associations with endometriosis were found in trials with Asian women.^48,54 The association was not confirmed in Caucasian women in studies with similar sample sizes.^50,53 All four endometriosis studies investigated the same base-pair change, A > G. For migraine, the studies for this SNP showed contradictory results^55,56 (Table 1).

rs2228480

In an Asian study, no association with endometriosis was found.⁶¹ For migraine, an association was significant in two of eight studies with the same alleles G > A^55,62 (Table 1).

rs1801132

No association with endometriosis was found and a significant association with migraine was reported in three studies including large sample sizes of Caucasian women, two of them investigating the base-pair change G > C. The largest study investigated a C > G change.⁶⁴ Seven studies did not find an association for this SNP with migraine, two also studying the C > G change.^57,58 The majority of these seven studies included Asian populations.^55–57,121

ESR2 gene

One overlapping polymorphism that could possibly play a role in the common genetic cause of the two diseases was found in the ESR2 gene (Table 2).

rs4986938

Endometriosis and migraine were both associated with this polymorphism in four of eight studies. Two studies with Caucasian endometriosis patients found a significant association with the base-pair change G > A,^73,74 while such an association was not confirmed in women of Asian descent.^61,75 Moreover, two studies in Caucasian migraineurs, but not those including Asian populations, reported an association with this SNP.^55,67,68,121

rs1256049

One of two studies found an association with endometriosis.⁷⁶ A total of three Asian studies investigated this polymorphism, but none found an association with endometriosis or migraine.^55,56,61

PGR gene

PROGINS

Four studies showed an association with endometriosis. All four studies included Caucasian participants.^78,79,81,93 The sample sizes of these four studies were relatively small compared with the studies without an association.^49,82,84,85One association was found in a migraine trial with Caucasian women.⁸⁶ Two other migraine trials with Caucasian women and slightly smaller sample sizes did not find an association.^66,67

rs1042838

No associations were found, for neither endometriosis nor migraine.^{40,57,61,83,87,89}

AR gene

CAG repeat

Three studies showed an association with endometriosis. All three studies consisted of participants of Asian ethnicity.^90–92 Three other studies did not find an association, one of which was a study investigating an association with migraine.^80,86,94

FSHR gene

rs6166

One of five studies found an association with endometriosis in Turkish women, and one of three studies found an association with Caucasian migraineurs.^68,95

NRIP1 gene

rs2229741

No association was found with endometriosis in a small study with Caucasian women.¹⁰² One of three studies showed an association in Caucasian migraineurs.⁶⁷

COMT gene

rs4680

In six studies investigating an association with endometriosis, none were found.^{39,40,72,98,104,105} Two of eight studies found an association with migraine. One of the trials included more than 1000 participants.¹⁰⁷ On the contrary, another very large trial did not find an association.¹¹² In both groups, the ethnicity was considered Caucasian. The other association was found in a small Turkish trial focused on the G > A pair change.¹⁰⁶ Six studies with female migraineurs did not find an association.^{107–109,111–113} Four of these six investigated the same base pair change, G > A.

CYP1A1 gene

rs4646903 (MspI)

Two of eight studies showed an association with endometriosis. The case-control study with the smaller sample size investigated the T > C change.¹¹⁵ Four Asian studies also investigated this base pair change, but found no association.^{72,105,116–119} No association with migraine was found.¹¹⁰

rs1048943

No associations were found in endometriosis patients or migraine patients.^72,110

CYP19A1 gene

rs10046

Within five studies, no significant associations with endometriosis were found in either Asian or Caucasian study populations.^{49,61,74,124,126} Two of five studies, both of them in Asian populations, found an association with migraine. In contrast, a large Chinese case-control study did not find an association.⁵⁵

rs4646

No association with endometriosis was found in a Caucasian study population.⁷⁴ In one Indian study, migraine was associated with this polymorphism.⁵⁶ However, two other large studies found no association.^55,67

rs700519

None of the three studies examined found an association with endometriosis, and neither did one study with migraineurs.^37,72,98,110

Discussion

The objectives of the present study were to provide an extensive review of sex hormone-related polymorphisms studied in endometriosis and migraine. Improved understanding of this comorbidity might facilitate early diagnosis and specific therapy. We found many probable overlapping SNPs in the candidate genes (Table 2), with mostly contradictory results, presumably due to some limitations of the included studies.

Both endometriosis and migraine are complex conditions with a variety of phenotypes. The heterogeneity of the control groups in the endometriosis studies constitutes a source of critique, as some women who have had a laparoscopy might not be representative of the normal population, and women in control groups without a laparoscopy might suffer from asymptomatic endometriosis with a probability of 2–11%.⁵ Preferably, controls would be pain-free, fertile women in whom the absence of endometriosis is confirmed by surgery.¹²⁶ Such a control group will not only be difficult to establish in large study populations, but is also not acceptable for ethical reasons. A recent systematic review of polymorphisms and endometriosis confirmed the importance of being cautious regarding the criteria for selecting the control population.³³ To reduce heterogeneity, we excluded studies with self-reported endometriosis, recurrent endometriosis, female newborns, and men as controls. Arguably, including postmenopausal women in control groups is associated with the problem that these now asymptomatic women might have suffered from endometriosis in their reproductive years. Postmenopausal women could still have the genetic makeup predisposing them to endometriosis.

Another possible explanation is failed replication in subsequent studies due to the candidate-gene approach. Candidate-gene association studies have been widely used in the genetics of complex traits and diseases. This approach is based on the a priori selection of candidate genes with a hypothetical role in the pathogenesis of the disease and uses indirect genotyping methods.¹²⁷ Nowadays, these methods are mostly obsolete due to the rise of direct-sequencing technologies.¹²⁸ Indirect genotyping methods have a higher chance of yielding false positives compared to direct-sequencing technologies. In a simulation study, 968 of 1000 simulations (96.8%) produced at least one false positive.¹²⁹ Other drawbacks of candidate-gene studies are the small sample sizes and the lack of standardized genotyping methodologies. However, there is no universal genotyping method because choosing a suitable genotyping method for a certain variant depends on multiple factors, for example, the number of variants in the specified gene. Finally, problems with population stratification can occur in candidate-gene studies when cases and controls are poorly matched and, consequently, are responsible for significant associations.¹³⁰ We are aware that this approach has a limited ability to include all possible causative genes and polymorphisms. However, from a clinical point of view, we carefully decided to only include studies examining the candidate sex-hormone genes in question to better understand the role of these sex-hormones and to enable more targeted treatments for the comorbidity. Although subject to criticism, this approach still proves to be a robust tool for studying the genetic makeup, especially for diseases with complex traits.¹³¹

We found three overlapping sex hormone-associated polymorphisms in the estrogen receptor genes (ESR1 and ESR2), in particular the SNPs rs2234693 (Pvull), rs9340799 (Xbal) and rs4986938 (AluI)^{48–51,54–57,67,68,73,74} (Table 2). Both Caucasian and Asian women with endometriosis showed an association between the disease and rs2234693 (Pvull), but for migraine the association was found only in Asian women.^55–58 While rs9340799 (Xbal) was associated with endometriosis and migraine in Asian women, no association was found in Caucasian women.^50,53 Both conditions were significantly associated with rs4986938 (AluI) in specifically Caucasian women. The differences between the findings in Asian and Caucasian populations demonstrate the importance of ethnicity when performing and interpreting genetic studies. The prevalence of endometriosis seems to differ among Asian and Caucasian populations. Asian women are significantly more likely to be diagnosed with endometriosis (OR 1.63, 95% CI 1.03–2.58).¹³²

Some studies did not specify the allelic change in the polymorphism. However, one SNP can have several different base-pair changes and allele frequencies can vary in different ethnicities. This information was reviewed in the current dbSNP database.⁴⁶

In the ESR1 gene, rs1801132 has been found to have an association with migraine in women, but no studies have investigated this polymorphism in women with endometriosis. Three repeat polymorphisms, TA repeat (ESR1 gene), CAG repeat (AR gene), and TTTA repeat (CYP19A1 gene) all have probable associations with endometriosis, but have not yet been investigated in migraineurs. We found overlapping polymorphisms for PROGINS (PGR gene) and rs6166 (FSHR gene), but more powered studies are required to understand if there is a significant association. Regarding the FSHB gene, rs11031006 is associated with endometriosis, but migraine studies are needed. General overlaps in the metabolizing enzymes have been assessed in our literature search for COMT, NRIP1, CYP1A1, CYP19A1, but no overlapping SNPs have been found and more data is needed (Table 2).

The strengths of this study were the strict inclusion and exclusion criteria to reduce selection bias. We included only case-control studies. To ensure the diagnosis, we only included studies with endometriosis diagnosed by laparoscopy and/or histology, and the majority was ASRM-classified. Migraineurs were diagnosed based on the criteria specified by the IHS.² A limitation of our study was the stratification into two ethnic groups, resulting in recruitment bias. Arguably, this could have been more specific–for example, stratifying for European, Hispanic, and Turkish populations. It is important to note that ethnicity and race have different definitions, although within medical literature these are often used interchangeably.¹³² In female lifetime, the clinical pattern of migraine is linked to reproductive events with an increase around puberty, a peak during fertile age, and a decrease after menopause.¹³³ Age was considered, but studies for women in menopause or before menarche were not available and therefore could not be included. Other mechanisms might be involved in childhood migraine.

Migraines appear to occur more commonly in patients with endometriosis than in the general population.¹³⁴ The prevalence of migraine is significantly higher in women with endometriosis as compared to women without endometriosis.^135–137 We hypothesize that endometriosis and migraine are comorbidities in a subset of women. A recent study confirmed this comorbidity and suggested a non-causal relationship between the two traits.⁴ Nevertheless, mechanistic insights for both conditions are still lacking. In addition to differences on the hormone receptor level or hormone metabolism level, this also could be a shared problem in the immune response in women with the comorbidities.

Table 2 shows an overview of overlapping genes in both conditions, which were only found in estrogen receptor genes. It seems estrogen plays a central role in the genetic link underlying the comorbidity of endometriosis and migraine. Biologically, estrogens exert their effects via the estrogen receptors localized in epithelial, stromal, and vascular cells. Progestins antagonize estrogen actions in the reproductive tissues, brain, and nerve cells by reducing estrogen receptor expression.¹³⁸ Women with overlapping estrogen receptor polymorphisms could experience a higher improvement in symptoms with estrogen-suppression by continuous treatment with progestins. The majority of women in the reproductive years use hormonal contraception. However, combined hormonal contraception frequently has a negative impact on migraine.¹³⁹ Whereas treatment with progestin-only has a positive impact on both conditions.^30,140–143 Therefore, patients with the comorbidity of migraine and endometriosis would profit if their attending physician could identify the co-occurrence to optimize hormonal treatment.

Conclusion

This literature review gives an overview of the shared sex hormone polymorphisms in women with migraine and endometriosis. Furthermore, we have identified SNPs potentially related to these conditions, which are relevant for future research. To confirm possible associations with other sex-hormone genes, larger studies are needed, in which ethnicity needs to be taken into account. We hypothesize that ESR1 and ESR2 may play a role in the genetic cause of endometriosis and migraine. For optimal treatment and patient care, we recommend actively exploring the comorbidity of migraine and endometriosis.

Supplemental Material

sj-docx-1-whe-10.1177_17455057221111315 – Supplemental material for Sex hormone-related polymorphisms in endometriosis and migraine: A narrative review

Supplemental material, sj-docx-1-whe-10.1177_17455057221111315 for Sex hormone-related polymorphisms in endometriosis and migraine: A narrative review by Joy-Fleur van der Vaart and Gabriele Susanne Merki-Feld in Women’s Health

Footnotes

Author contribution(s)

Joy-Fleur van der Vaart: Conceptualization; Data curation; Formal analysis; Investigation; Methodology; Writing—original draft; Writing—review and editing. Gabriele Susanne Merki-Feld: Conceptualization; Methodology; Supervision.

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Ethical approval

According to the cantonal Swiss Ethic Committee of Zürich http://www.kek.zh.ch/ and Swiss Association of Research Ethics Committees ethics approval is not applicable for literature reviews.

ORCID iD

Joy-Fleur van der Vaart

Supplemental material

Supplemental material for this article is available online.

References

Zondervan

Becker

Koga

, et al. Endometriosis. Nat Rev Dis Primers 2018; 4(1): 9.

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38(1): 1–211.

Nyholt

Gillespie

Merikangas

, et al. Common genetic influences underlie comorbidity of migraine and endometriosis. Genet Epidemiol 2009; 33(2): 105–113.

Adewuyi

Sapkota

, International Endogene Consortium (IEC), et al. Shared molecular genetic mechanisms underlie endometriosis and migraine comorbidity. Genes 2020; 11(3): 268.

Zondervan

Becker

Missmer

. Endometriosis. N Engl J Med 2020; 382(13): 1244–1256.

Stovner

Nichols

Steiner

, et al. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018; 17(11): 954–976.

Buse

Fanning

Reed

, et al. Life with migraine: effects on relationships, career, and finances from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache 2019; 59(8): 1286–1299.

Agosti

. Migraine burden of disease: from the patient’s experience to a socio-economic view. Headache 2018; 58(suppl. 1): 17–32.

Simoens

Dunselman

Dirksen

, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod 2012; 27(5): 1292–1299.

10.

Vos

Barber

Bell

, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386(9995): 743–800.

11.

Burch

Buse

Lipton

. Migraine: epidemiology, burden, and comorbidity. Neurol Clin 2019; 37(4): 631–649.

12.

Treloar

O’Connor

, et al. Genetic influences on endometriosis in an Australian twin sample. sueT@qimr.edu.au. Fertil Steril 1999; 71(4): 701–710.

13.

Saha

Pettersson

Svedberg

, et al. Heritability of endometriosis. Fertil Steril 2015; 104(4): 947–952.

14.

Honkasalo

Kaprio

Winter

, et al. Migraine and concomitant symptoms among 8167 adult twin pairs. Headache 1995; 35(2): 70–78.

15.

Mulder

Van Baal

Gaist

, et al. Genetic and environmental influences on migraine: a twin study across six countries. Twin Res 2003; 6(5): 422–431.

16.

Polderman

Benyamin

De Leeuw

, et al. Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat Genet 2015; 47(7): 702–709.

17.

Vercellini

Viganò

Somigliana

, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 2014; 10(5): 261–275.

18.

Vetvik

MacGregor

. Menstrual migraine: a distinct disorder needing greater recognition. Lancet Neurol 2021; 20(4): 304–315.

19.

MacGregor

. Menstrual migraine: a clinical review. J Fam Plann Reprod Health Care 2007; 33(1): 36–47.

20.

Bulun

Yilmaz

Sison

, et al. Endometriosis. Endocr Rev 2019; 40(4): 1048–1079.

21.

Vetvik

MacGregor

. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol 2017; 16(1): 76–87.

22.

MacGregor

Frith

Ellis

, et al. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 2006; 67(12): 2154–2158.

23.

Somerville

. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972; 22(4): 355–365.

24.

Sulak

Willis

Kuehl

, et al. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 2007; 47(1): 27–37.

25.

Aegidius

Zwart

Hagen

, et al. Oral contraceptives and increased headache prevalence: the Head-HUNT Study. Neurology 2006; 66(3): 349–353.

26.

Teepker

Peters

Kundermann

, et al. The effects of oral contraceptives on detection and pain thresholds as well as headache intensity during menstrual cycle in migraine. Headache 2011; 51(1): 92–104.

27.

Massiou

MacGregor

. Evolution and treatment of migraine with oral contraceptives. Cephalalgia 2000; 20(3): 170–174.

28.

Coffee

Sulak

Hill

, et al. Extended cycle combined oral contraceptives and prophylactic frovatriptan during the hormone-free interval in women with menstrual-related migraines. J Womens Health 2014; 23(4): 310–317.

29.

Merki-Feld

Imthurn

Langner

, et al. Headache frequency and intensity in female migraineurs using desogestrel-only contraception: a retrospective pilot diary study. Cephalalgia 2013; 33(5): 340–346.

30.

Merki-Feld

Imthurn

Gantenbein

, et al. Effect of desogestrel 75 µg on headache frequency and intensity in women with migraine: a prospective controlled trial. Eur J Contracept Reprod Health Care 2019; 24(3): 175–181.

31.

Strowitzki

Marr

Gerlinger

, et al. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod 2010; 25(3): 633–641.

32.

Caruso

Iraci

Cianci

, et al. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive. J Endocrinol Invest 2016; 39(8): 923–931.

33.

Méar

Herr

Fauconnier

, et al. Polymorphisms and endometriosis: a systematic review and meta-analyses. Hum Reprod Update 2020; 26(1): 73–102.

34.

Fabjani

Tong

Czerwenka

, et al. Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer in Austrian women. Breast Cancer Res Treat 2002; 72(2): 131–137.

35.

Patel

Rudnicki

, et al. Progesterone resistance in endometriosis: origins, consequences and interventions. Acta Obstet Gynecol Scand 2017; 96(6): 623–632.

36.

Kado

Kitawaki

Obayashi

, et al. Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women. Hum Reprod 2002; 17(4): 897–902.

37.

Tsuchiya

Nakajima

Yokoi

. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 2005; 227(2): 115–124.

38.

Docquier

Garcia

Savatier

, et al. Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells. Mol Endocrinol 2013; 27(9): 1429–1441.

39.

Wieser

Wenzl

Tempfer

, et al. Catechol-O-methyltransferase polymorphism and endometriosis. J Assist Reprod Genet 2002; 19(7): 343–348.

40.

Trabert

Schwartz

Peters

, et al. Genetic variation in the sex hormone metabolic pathway and endometriosis risk: an evaluation of candidate genes. Fertil Steril 2011; 96(6): 1401.e3–1406.e3.

41.

Schürks

Rist

Kurth

. Sex hormone receptor gene polymorphisms and migraine: a systematic review and meta-analysis. Cephalalgia 2010; 30(11): 1306–1328.

42.

Zhao

Zhu

Xiao

, et al. Genetic variants in migraine: a field synopsis and systematic re-analysis of meta-analyses. J Headache Pain 2020; 21(1): 13.

43.

Sapkota

Steinthorsdottir

Morris

, et al. Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism. Nat Commun 2017; 8: 15539.

44.

Christofolini

Vilarino

Mafra

, et al. Combination of polymorphisms in luteinizing hormone β, estrogen receptor β and progesterone receptor and susceptibility to infertility and endometriosis. Eur J Obstet Gynecol Reprod Biol 2011; 158(2): 260–264.

45.

Cardoso

Machado

Ferrari

, et al. Combined effect of the PGR +331C > T, CYP17A1 -34A > G and CYP19A1 1531G > a polymorphisms on the risk of developing endometriosis. Rev Bras Ginecol Obstet 2017; 39(6): 273–281.

46.

Sherry

Ward

Kholodov

, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001; 29(1): 308–311.

47.

Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997; 67(5): 817–821.

48.

Hsieh

Wang

Chang

, et al. Estrogen receptor alpha-351 XbaI*G and -397 PvuII*C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma. Mol Hum Reprod 2007; 13(2): 117–122.

49.

Lamp

Peters

Reinmaa

, et al. Polymorphisms in ESR1, ESR2 and HSD17B1 genes are associated with fertility status in endometriosis. Gynecol Endocrinol 2011; 27(6): 425–433.

50.

Paskulin

Cunha-Filho

Paskulin

, et al. ESR1 rs9340799 is associated with endometriosis-related infertility and in vitro fertilization failure. Dis Markers 2013; 35(6): 907–913.

51.

Kitawaki

Obayashi

Ishihara

, et al. Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. Hum Reprod 2001; 16(1): 51–55.

52.

Govindan

Shaik

Vedicherla

, et al. Estrogen receptor-alpha gene (T/C) Pvu II polymorphism in endometriosis and uterine fibroids. Dis Markers 2009; 26(4): 149–154.

53.

Renner

Strick

Oppelt

, et al. Evaluation of clinical parameters and estrogen receptor alpha gene polymorphisms for patients with endometriosis. Reproduction 2006; 131(1): 153–161.

54.

Xie

Wang

, et al. Association of estrogen receptor alpha and interleukin-10 gene polymorphisms with endometriosis in a Chinese population. Fertil Steril 2009; 92(1): 54–60.

55.

Fang

Lin

, et al. New evidence for involvement of ESR1 gene in susceptibility to Chinese migraine. J Neurol 2017; 264(1): 81–87.

56.

Ghosh

Joshi

Pradhan

, et al. Potential role of aromatase over estrogen receptor gene polymorphisms in migraine susceptibility: a case control study from North India. PLoS One 2012; 7(4): e34828.

57.

Joshi

Pradhan

Mittal

. Role of the oestrogen receptor (ESR1 PvuII and ESR1 325 C->G) and progesterone receptor (PROGINS) polymorphisms in genetic susceptibility to migraine in a North Indian population. Cephalalgia 2010; 30(3): 311–320.

58.

Colson

Lea

Quinlan

, et al. No role for estrogen receptor 1 gene intron 1 Pvu II and exon 4 C325G polymorphisms in migraine susceptibility. BMC Med Genet 2006; 7: 12.

59.

Kim

Choi

Jun

, et al. Estrogen receptor dinucleotide repeat polymorphism is associated with minimal or mild endometriosis. Fertil Steril 2005;84(3): 774–777.

60.

Hsieh

Chang

Tsai

, et al. Estrogen receptor alpha dinucleotide repeat and cytochrome P450c17alpha gene polymorphisms are associated with susceptibility to endometriosis. Fertil Steril 2005;83(3): 567–572.

61.

Yang

Chang

, et al. Screening of a panel of steroid-related genes showed polymorphisms of aromatase genes confer susceptibility to advanced stage endometriosis in the Taiwanese Han population. Taiwan J Obstet Gynecol 2013; 52(4): 485–492.

62.

Colson

Lea

Quinlan

, et al. The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups. Neurogenetics 2004; 5(2): 129–133.

63.

Coşkun

Yůcel

Çim

, et al. Contribution of polymorphisms in ESR1, ESR2, FSHR, CYP19A1, SHBG, and NRIP1 genes to migraine susceptibility in Turkish population. J Genet 2016; 95(1): 131–140.

64.

Kaunisto

Kallela

Hämäläinen

, et al. Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia 2006; 26(12): 1462–1472.

65.

Oterino

Pascual

Ruiz de Alegría

, et al. Association of migraine and ESR1 G325C polymorphism. Neuroreport 2006;17(1): 61–64.

66.

Corominas

Ribasés

Cuenca-León

, et al. Lack of association of hormone receptor polymorphisms with migraine. Eur J Neurol 2009; 16(3): 413–415.

67.

Rodriguez-Acevedo

Smith

Roy

, et al. Genetic association and gene expression studies suggest that genetic variants in the SYNE1 and TNF genes are related to menstrual migraine. J Headache Pain 2014; 15(1): 62.

68.

Oterino

Toriello

Cayón

, et al. Multilocus analyses reveal involvement of the ESR1, ESR2, and FSHR genes in migraine. Headache 2008; 48(10): 1438–1450.

69.

Wang

Maitituoheti

, et al. Association of an oestrogen receptor gene polymorphism in Chinese Han women with endometriosis and endometriosis-related infertility. Reprod Biomed Online 2013;26(1):93–98.

70.

Matsuzaka

Kikuti

Izumi

, et al. Failure to detect significant association between estrogen receptor-alpha gene polymorphisms and endometriosis in Japanese women. Environ Health Prev Med 2012;17(5):423–428.

71.

Sato

Nogueira-de-Souza

D’Amora

, et al. Intron 1 and exon 1 alpha estrogen receptor gene polymorphisms in women with endometriosis. Fertil Steril 2008;90(6): 2086–2090.

72.

Huber

Keck

Hefler

, et al. Ten estrogen-related polymorphisms and endometriosis: a study of multiple gene-gene interactions. Obstet Gynecol 2005; 106(5 pt 1): 1025–1031.

73.

Bianco

Christofolini

Mafra

, et al. +1730 G/A polymorphism of the estrogen receptor beta gene (ERbeta) may be an important genetic factor predisposing to endometriosis. Acta Obstet Gynecol Scand 2009; 88(12): 1397–1401.

74.

Szaflik

Smolarz

Romanowicz

, et al. Polymorphisms in the 3’UTR region of ESR2 and CYP19A1 genes in women with endometriosis. Eur J Obstet Gynecol Reprod Biol 2020; 250: 241–245.

75.

Lee

Kim

Choi

, et al. Estrogen receptor beta gene +1730 G/A polymorphism in women with endometriosis. Fertil Steril 2007; 88(4): 785–788.

76.

Silva

RCPC

Costa

Bordin

, et al. RsaI polymorphism of the ERβ gene in women with endometriosis. Genet Mol Res 2011; 10(1): 465–470.

77.

Smolarz

Romanowicz

. Association between single nucleotide polymorphism of the CYP19A1 and ESR2 genes and endometriosis. Arch Gynecol Obstet 2021;304(2):439–445.

78.

Costa

Silva

RCPC

Frare

, et al. Polymorphism of the progesterone receptor gene associated with endometriosis in patients from Goias, Brazil. Genet Mol Res 2011; 10(3): 1364–1370.

79.

De Carvalho

Nogueira-De-Souza

Costa

, et al. Genetic polymorphisms of cytochrome P450cl7alpha (CYP17) and progesterone receptor genes (PROGINS) in the assessment of endometriosis risk. Gynecol Endocrinol 2007; 23(1): 29–33.

80.

Lattuada

Viganò

Somigliana

, et al. Androgen receptor gene cytosine, adenine, and guanine trinucleotide repeats in patients with endometriosis. J Soc Gynecol Investig 2004; 11(4): 237–240.

81.

Wieser

Schneeberger

Tong

, et al. PROGINS receptor gene polymorphism is associated with endometriosis. Fertil Steril 2002; 77(2): 309–312.

82.

Treloar

Zhao

Armitage

, et al. Association between polymorphisms in the progesterone receptor gene and endometriosis. Mol Hum Reprod 2005; 11(9): 641–647.

83.

Treloar

Wicks

Nyholt

, et al. Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26. Am J Hum Genet 2005; 77(3): 365–376.

84.

Gimenes

Bianco

Mafra

, et al. The progins progesterone receptor gene polymorphism is not related to endometriosis-associated infertility or to idiopathic infertility. Clinics 2010; 65(11): 1073–1076.

85.

Govindan

Ahmad

Vedicherla

, et al. Association of progesterone receptor gene polymorphism (PROGINS) with endometriosis, uterine fibroids and breast cancer. Cancer Biomark 2007; 3(2): 73–78.

86.

Colson

Lea

Quinlan

, et al. Investigation of hormone receptor genes in migraine. Neurogenetics 2005; 6(1): 17–23.

87.

Van Kaam

Romano

Schouten

, et al. Progesterone receptor polymorphism +331G/A is associated with a decreased risk of deep infiltrating endometriosis. Hum Reprod 2007; 22(1): 129–135.

88.

Palmirotta

Barbanti

Ialongo

, et al. Progesterone receptor gene (PROGINS) polymorphism correlates with late onset of migraine. DNA Cell Biol 2015; 34(3): 208–212.

89.

Gentilini

Vigano

Carmignani

, et al. Progesterone receptor +331G/A polymorphism in endometriosis and deep-infiltrating endometriosis. Fertil Steril 2008;90(4): 1243–1245.

90.

Hsieh

Chang

Tsai

, et al. Androgen receptor trinucleotide polymorphism in endometriosis. Fertil Steril 2001; 76(2): 412–413.

91.

Shaik

Govindan

Kodati

, et al. Polymorphic (CAG)n repeats in the androgen receptor gene: a risk marker for endometriosis and uterine leiomyomas. Hematol Oncol Stem Cell Ther 2009; 2(1): 289–293.

92.

Shin

Choi

, et al. Androgen receptor cytosine, adenine, and guanine trinucleotide repeat polymorphism in Korean patients with endometriosis: a case-control study. Eur J Obstet Gynecol Reprod Biol 2017; 218: 1–4.

93.

Lattuada

Somigliana

Viganò

, et al. Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS? Clin Endocrinol 2004; 61(2): 190–194.

94.

Tong

Deng

Sun

, et al. The relationship between CAG repeat length polymorphism and infertility in Southern Chinese Han women. J Endocrinol Invest 2010; 33(8): 559–563.

95.

Kerimoglu

Yılmaz

Pekin

, et al. Follicle-stimulating hormone receptor gene polymorphisms in women with endometriosis. Arch Gynecol Obstet 2015; 291(6): 1411–1416.

96.

Liaqat

Arifa

Asif

, et al. Association of FSHR gene polymorphisms with endometriosis in women visiting tertiary-care hospitals of Lahore, Pakistan. J Pak Med Assoc 2021;71(4): 1118–1122.

97.

André

Martins Trevisan

Pedruzzi

, et al. The impact of FSHR gne polymorphisms Ala307Thr and Asn680Ser in the endometriosis development. DNA Cell Biol 2018;37(6): 584–591.

98.

Wang

Cheng

, et al. Functional analyses of endometriosis-related polymorphisms in the estrogen synthesis and metabolism-related genes. PLoS One 2012; 7(11): e47374.

99.

Schmitz

Souza

Genro

, et al. LH (Trp8Arg/Ile15Thr), LHR (insLQ) and FSHR (Asn680Ser) polymorphisms genotypic prevalence in women with endometriosis and infertility. J Assist Reprod Genet 2015;32(6): 991–997.

100.

Angioni

D’Alterio

Coiana

, et al. Genetic characterization of endometriosis patients: Review of the literature and a prospective cohort study on a mediterranean population. Int J Mol Sci 2020;21(5). DOI: 10.3390/ijms21051765.

101.

Matalliotakis

Zervou

Matalliotaki

, et al. The role of gene polymorphisms in endometriosis. Mol Med Rep 2017;16(5): 5881–5886.

102.

Caballero

Ruiz

Sainz

, et al. Preliminary molecular genetic analysis of the Receptor Interacting Protein 140 (RIP140) in women affected by endometriosis. J Exp Clin Assist Reprod 2005; 2: 11.

103.

Pollock

Sutherland

Maher

, et al. The NRP1 migraine risk variant shows evidence of association with menstrual migraine. J Headache Pain 2018;19(1): 31.

104.

Christofolini

Teles

Vilarino

, et al. COMT polymorphism and the risk of endometriosis-related infertility. Gynecol Endocrinol 2011; 27(12): 1099–1102.

105.

Juo

Wang

Lee

, et al. CYP17, CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women. Hum Reprod 2006; 21(6): 1498–1502.

106.

Emin Erdal

Herken

Yilmaz

, et al. Significance of the catechol-O-methyltransferase gene polymorphism in migraine. Brain Res Mol Brain Res 2001; 94(1–2): 193–196.

107.

Sullivan

Atkinson

Cutrer

. Hormonally modulated migraine is associated with single-nucleotide polymorphisms within genes involved in dopamine metabolism. Open J Genet 2013; 3(2): 38–45.

108.

De Marchis

Barbanti

Palmirotta

, et al. Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study. J Headache Pain 2015; 16: 520.

109.

Todt

Netzer

Toliat

, et al. New genetic evidence for involvement of the dopamine system in migraine with aura. Hum Genet 2009; 125(3): 265–279.

110.

Sutherland

Champion

Plays

, et al. Investigation of polymorphisms in genes involved in estrogen metabolism in menstrual migraine. Gene 2017; 607: 36–40.

111.

Takigawa

Kowa

Nakashima

. No associations between five polymorphisms in COMT gene and migraine. Acta Neurol Scand 2017; 135(2): 225–230.

112.

Hagen

Pettersen

Stovner

, et al. The association between headache and Val158Met polymorphism in the catechol-O-methyltransferase gene: the HUNT Study. J Headache Pain 2006; 7(2): 70–74.

113.

Park

Lee

Kim

, et al. Genetic contribution of Catechol-O-methyltransferase polymorphism in patients with migraine without aura. J Clin Neurol 2007; 3(1): 24–30.

114.

Arvanitis

Koumantakis

Goumenou

, et al. CYP1A1, CYP19, and GSTM1 polymorphisms increase the risk of endometriosis. Fertil Steril 2003;79 Suppl 1: 702–709.

115.

Barbosa

De Souza

Frare

, et al. Association of CYP1A1 (cytochrome P450) MspI polymorphism in women with endometriosis. Genet Mol Res. Epub ahead of print 26 August 2016. DOI: 10.4238/gmr.15038389.

116.

Babu

Reddy

Deendayal

, et al. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and their relationship with advanced stages of endometriosis in South Indian women. Pharmacogenet Genomics 2005; 15(3): 167–172.

117.

Rozati

Reddy

Giragalla

, et al. The CYP1A1 and GSTM1 genetic polymorphisms and susceptibility to endometriosis in women from South India. Fertil Steril 2008; 2: 105–112.

118.

Babaki

Mehrjardi

Firouzabadi

, et al. Relationship between MspI polymorphism of CYP1A1 gene and the risk of endometriosis in an Iranian population: a case-control study. Int J Reprod Biomed 2018; 16(10): 637–640.

119.

Guo

Yang

, et al. Polymorphisms of dioxin receptor complex components and detoxification-related genes jointly confer susceptibility to advanced-stage endometriosis in the Taiwanese Han population. Am J Reprod Immunol 2012; 67(2): 160–168.

120.

Bozdag

Alp

Saribas

, et al. CYP17 and CYP2C19 gene polymorphisms in patients with endometriosis. Reprod Biomed Online 2010;20(2): 286–290.

121.

Szczepańska

Wirstlein

Skrzypczak

, et al. Polymorphic variants of CYP17 and CYP19A and risk of infertility in endometriosis. Acta Obstet Gynecol Scand 2013; 92(10): 1188–1193.

122.

Vietri

Cioffi

Sessa

, et al. CYP17 and CYP19 gene polymorphisms in women affected with endometriosis. Fertil Steril 2009;92(5): 1532–1535.

123.

Zhao

Nyholt

, et al. Common variation in the CYP17A1 and IFIT1 genes on chromosome 10 does not contribute to the risk of endometriosis. Open Reprod Sci J 2008;1: 35–40.

124.

Wang

, et al. CYP19 gene variant confers susceptibility to endometriosis-associated infertility in Chinese women. Exp Mol Med 2014; 46: e103.

125.

Hur

Lee

, et al. Polymorphisms and haplotypes of the gene encoding the estrogen-metabolizing CYP19 gene in Korean women: no association with advanced-stage endometriosis. J Hum Genet 2007;52(9): 703–711.

126.

Greaves

Critchley

HOD

Horne

, et al. Relevant human tissue resources and laboratory models for use in endometriosis research. Acta Obstet Gynecol Scand 2017; 96(6): 644–658.

127.

Kwon

Goate

. The candidate gene approach. Alcohol Res Health 2000; 24(3): 164–168.

128.

Hashim

Al-Shuhaib

MBS

. Exploring the potential and limitations of PCR-RFLP and PCR-SSCP for SNP detection: a review. J Appl Biotechnol Rep 2019; 6(4): 137–144.

129.

Sullivan

. Spurious genetic associations. Biol Psychiatry 2007; 61(10): 1121–1126.

130.

Tabor

Risch

Myers

. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002; 3(5): 391–397.

131.

Newton-Cheh

Hirschhorn

. Genetic association studies of complex traits: design and analysis issues. Mutat Res 2005; 573(1–2): 54–69.

132.

Bougie

Yap

Sikora

, et al. Influence of race/ethnicity on prevalence and presentation of endometriosis: a systematic review and meta-analysis. BJOG 2019; 126(9): 1104–1115.

133.

Faubion

Batur

Calhoun

. Migraine throughout the female reproductive life cycle. Mayo Clin Proc 2018; 93(5): 639–645.

134.

Yang

Wang

, et al. Women with endometriosis are more likely to suffer from migraines: a population-based study. PLoS One 2012; 7(3): e33941.

135.

Maitrot-Mantelet

Hugon-Rodin

Vatel

, et al. Migraine in relation with endometriosis phenotypes: results from a French case-control study. Cephalalgia 2020; 40(6): 606–613.

136.

Miller

Missmer

Vitonis

, et al. Prevalence of migraines in adolescents with endometriosis. Fertil Steril 2018; 109(4): 685–690.

137.

Ferrero

Pretta

Bertoldi

, et al. Increased frequency of migraine among women with endometriosis. Hum Reprod 2004; 19(12): 2927–2932.

138.

Jayaraman

Pike

. Progesterone attenuates oestrogen neuroprotection via downregulation of oestrogen receptor expression in cultured neurones. J Neuroendocrinol 2009; 21(1): 77–81.

139.

Bentivegna

Luciani

Scarso

, et al. Hormonal therapies in migraine management: current perspectives on patient selection and risk management. Expert Rev Neurother 2021; 21: 1347–1355.

140.

Merki-Feld

Imthurn

Seifert

, et al. Desogestrel-only contraception may reduce headache frequency and improve quality of life in women suffering from migraine. Eur J Contracept Reprod Health Care 2013; 18(5): 394–400.

141.

Niu

Luo

Wang

, et al. Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis: results from a prospective, observational study. Medicine 2021; 100(6): e24597.

142.

Samy

Taher

Sileem

, et al. Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials. J Gynecol Obstet Hum Reprod 2021; 50(1): 101798.

143.

Tanmahasamut

Saejong

Rattanachaiyanont

, et al. Postoperative desogestrel for pelvic endometriosis-related pain: a randomized controlled trial. Gynecol Endocrinol 2017; 33(7): 534–539.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.09 MB